Wakefield Asset Management LLLP

Position in EXEL — Exelixis, Inc.

CIK 1600435 Englewood, CO

Position in EXEL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,790,090

New position

Shares Held

51,279

first reported quarter

Ownership

0.021%

of shares outstanding

% of Portfolio

0.85%

of 13F equity value

Holder Rank

#233

of 751 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wakefield Asset Management LLLP holds $3,644,910 across 4 Biotechnology names. EXEL ranks #1 (76.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	51,279	$2,790,090
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,276	$633,827
3	TECH	BIO-TECHNE Corp	3,128	$220,993
4			53,081	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,790,090	51,279	—	Shares	Defined	2026-08-11
No filing history on record for this holder in this stock.